Equities research analysts at StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK – Get Free Report) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the medical research company’s stock.
Check-Cap Stock Performance
Shares of CHEK opened at $1.15 on Thursday. Check-Cap has a 12 month low of $1.12 and a 12 month high of $3.94. The stock’s 50 day moving average is $1.62 and its two-hundred day moving average is $1.96. The firm has a market cap of $6.73 million, a P/E ratio of -0.38 and a beta of 0.36.
About Check-Cap
Further Reading
- Five stocks we like better than Check-Cap
- How to Use the MarketBeat Stock Screener
- Texas Roadhouse Stock Steering for New Highs This Year
- What is a Low P/E Ratio and What Does it Tell Investors?
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- Are Penny Stocks a Good Fit for Your Portfolio?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Check-Cap Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Check-Cap and related companies with MarketBeat.com's FREE daily email newsletter.